SCHEMBL4602102

SCHEMBL4602102

C=CC(=O)Oc1c(OCOC)cccc1Oc1ncc(C(F)(F)F)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.49
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C19 P33261 1/20 0.48
LMNA P02545 4/20 0.47
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
LIPE Q05469 1/20 0.44
MRGPRX4 Q96LA9 1/20 0.43
PPARG P37231 2/20 0.42
FFAR1 O14842 1/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 1/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4600789 0.92 HPGD (0.48) HPGDCYP1A2CYP3A4CYP2C19LMNA
SCHEMBL4601003 0.91 HPGD (0.48) HPGDCYP1A2CYP3A4CYP2C19LMNA
SCHEMBL4601774 0.89 HPGD (0.49) HPGDCYP1A2CYP3A4CYP2C19LMNA
Water SCHEMBL4601371 0.88 HPGD (0.48) HPGDCYP1A2CYP3A4CYP2C19LMNA
SCHEMBL4600147 0.88 HPGD (0.48) HPGDCYP1A2CYP3A4CYP2C19LMNA
SCHEMBL4601418 0.87 HPGD (0.51) HPGDCYP1A2CYP3A4CYP2C19LMNA
SCHEMBL4600376 0.86 HPGD (0.53) HPGDCYP1A2CYP3A4CYP2C19LMNA
SCHEMBL4601556 0.86 HPGD (0.47) HPGDCYP1A2CYP3A4CYP2C19LMNA
SCHEMBL4601848 0.86 HPGD (0.50) HPGDCYP1A2CYP3A4CYP2C19LMNA
SCHEMBL4601130 0.85 PPARG (0.49) HPGDCYP1A2CYP3A4CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed